＜4379＞ PHOTOSYNTH 390 +11

A significant increase of 3 days. Operating profit and loss for the first quarter (24/1-3) of the fiscal year ending 24/12 has been announced as a surplus of 59 million yen (deficit of 55 million yen in the same period last year). The steady increase in the number of units introduced of the “Akerun entrance/exit management system,” which is the main business, was successful, and it turned into a surplus. It is said that the consolidated group achieved a surplus on a quarterly basis for the first time. The full-year forecast was left unchanged with a surplus of 0.1 billion yen, but since it has already been exceeded as of the first quarter, expectations for an upward revision are spreading.

＜9164＞ Trite 558 -100

Stop cheap. Operating profit and loss for the first quarter (24/1-3) of the fiscal year ending 24/12 has been announced as a deficit of 653 million yen (deficit of 179 million yen in the same period last year). Sales revenue increased 11.2% from the previous fiscal year to 118.52 billion yen, securing an increase in sales. The medical welfare referral business was in the red due to a limited period, but it is said that it is as planned by the company. The full-year forecast was left unchanged with a surplus of 9.50 billion yen, up 26.4% from the previous fiscal year. Furthermore, it has also been clarified that preparations will be made for applying for a market classification change to the Tokyo Stock Exchange Prime Market.

＜4177＞ i-plug 1435 +175

A temporary stop increase has been added, and the year-to-date high has been updated. The operating profit and loss forecast for the fiscal year ending 25/3 has been announced as a surplus of 550 million yen, up 294.3% from the previous fiscal year. In addition to striving to raise awareness of the new graduate offer type job hunting service “OfferBox,” which is our main service, we will develop and expand new services and evolve products to enhance competitive advantage. Operating profit and loss for the fiscal year ended 2014/3 landed with a surplus of 139 million yen (deficit of 411 million yen in the previous fiscal year results), and exceeded the company plan (surplus of 0.79 million yen).

＜4419＞ Finatext 983 +68

The price has been high since the beginning of the year. The operating profit and loss forecast for the fiscal year ending 25/3 has been announced as a surplus of 686 million yen, up 234.8% from the previous fiscal year. We anticipate the acquisition of new partners and expansion of services with existing partners in the financial infrastructure business, and an increase in the number of contracts for “Alterna Data” alternative data for institutional investors in the big data analysis business. Operating profit and loss for the fiscal year ended 2014/3 landed at a surplus of 204 million yen (deficit of 328 million yen in previous fiscal year results). Profit and loss of the financial infrastructure business improved, etc., and it turned into a surplus.

＜7096＞ Stem Cell Research Institute 1830 -1

After high in the morning, turn off the value. It was announced that 25.00 yen (no dividend for the same period last year) will be implemented as a dividend commemorating the 25th anniversary of establishment at the end of the 2nd quarter of the fiscal year ending 25/3. This is the first dividend since establishment. There is no year-end dividend forecast, and it will be 25.00 yen per year. The operating profit forecast for the fiscal year ending 25/3 is 600 million yen, up 45.0% from the previous fiscal year. We will promote both digital and real marketing in the cell bank business, which is our main business. Operating profit for the fiscal year ended March 24 rose 39.1% to 413 million yen, making it a record high.

＜7062＞ Flare 1117 +150

A stop high has been added, and the year-to-date high has been updated. A medium-term management plan with an operating profit target of 2,001 billion yen for the fiscal year ending 27/3 has been announced. The operating profit forecast for the fiscal year ending 25/3 was 200 million yen, up 81.2% from the previous fiscal year. We anticipate a drastic increase in profit due to operational efficiency improvements in the massage direct management business and the establishment of bases for the institutional nursing service business. Operating profit for the fiscal year ended March 24 rose 647.5% to reach 110 million yen. The effects of the novel coronavirus infection have decreased, and the massage direct management business has remained steady.